Latest Feature

Sequent Medical CEO Wilder bets on braids

Sequent Medical CEO Tom Wilder tells MassDevice.com why his company's MicroBraid technology is a key differentiator in its Web device for treating brain aneurysms and, potentially, other conditions.

Masimo's Kiani on 'good-enough innovation,' Medtronic, Apple and 25 years of pus

In this DeviceTalks preview, we catch up with Masimo CEO Joe Kiani to discuss new challenges facing the company and how medtech can break the cycle of the era of 'good-enough' innovation.

Medicare: Medical device companies paid out $200m to physicians last year

Medical device companies' aggregate spend on payment and other gifts to physicians was at least $200 million last year, according to the U.S. Health & Human Services Dept., but critics (and the agency itself) flag widespread problems with the Open Payments database.

Checking on Orange County's medtech climate with OCTANe's Matthew Jenusaitis

Orange County, Calif.'s most-connected man, OCTANe's Matthew Jenusaitis talks to MassDevice.com about OCTANe's 2014 Medical Device Investor Forum.

What's behind the slump in early-stage medtech investment?

Blame the medical device tax and the U.S. regulatory environment for the slump in investment in early-stage medical technologies, Silicon Valley Bank's Ben Johnson tells MassDevice.com.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

Sources: Stryker weighs bid for Smith & Nephew

November 24, 2014 by MassDevice

Anonymous sources confirm speculation that Stryker is weighing a bid for British orthopedics rival Smith & Nephew.

Sources: Stryker weighs bid for Smith & Nephew

Zoll Medical seeks Japan's O.K. for temperature management tech

November 24, 2014 by Mark Hollmer

Zoll Medical wants Japanese regulatory approval to use its intravascular temperature management system to treat sudden cardiac arrests.

Zoll Medical seeks Japan's O.K. for temperature management tech

Zoll Medical wants to use its temperature management technology in Japan to treat sudden cardiac arrests, a new indication in that country for a system designed to cool or warm patients.

Boston Scientific backs Iowa Approach's atrial fibrillation device

November 24, 2014 by Brad Perriello

Iowa Approach says it landed an investment from Boston Scientific for the ablation device it's developing to treat atrial fibrillation.

Boston Scientific backs Iowa Approach's atrial fibrillation device

Reva Medical raises $25m for Fantom bioabsorbable stent

November 24, 2014 by Brad Perriello

Reva Medical closes a debt-and-options round worth $25 million to back the clinical program behind its Fantom bioabsorbable stent.

Reva Medical raises $25m for Fantom bioabsorbable stent

FDA adds 'black box' warning to power morcellator labels

November 24, 2014 by Brad Perriello

The FDA adds a 'black box' warning to the labels on laparoscopic power morcellators, advising against their use in most women slated for fibroid surgery.

FDA adds warnings to power morcellator labels

The FDA today put so-called "black box" warnings on the labels for laparoscopic power morcellators advising doctors that the devices, until recently a mainstay of gynecological surgery, be avoided in nearly all fibroid-removal procedures.

Second Sight Medical's IPO grosses $36m

November 24, 2014 by Brad Perriello

Second Sight Medical's initial public offering last week raised more than $36 million after its underwriter picked up an over-allotment option.

Second Sight Medical's IPO grosses $36m

J&J wants judge to make BSX pay $7.B over J&J's jilting by Guidant Corp. | Medtech legal news for the week of November 24, 2014

November 24, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: J&J demands $7.2 billion from Boston Scientific as trial begins; Bard still on the hook for its share of $5m pelvic mesh verdict; Boston Scientific to pay $18.5m in pelvic mesh case; Justice Dept. recoups $6B in False Claims Act cases

J&J demands $7.2 billion from Boston Scientific as trial begins

November 20, 2014 by MassDevice

Will Stryker bid on Smith & Nephew this week?

November 24, 2014 by Brad Perriello

Speculation mounts again about a possible Stryker offer for Smith & Nephew now that a 6-month no-bid period has ended.

Will Stryker bid on Smith & Nephew this week?

UPDATED Nov. 24 with analysis from Morgan Stanley.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp